Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Observational Study Measuring Sodium Improvement and Outcomes in Cancer Patients Treated for Moderate to Severe Hyponatremia Secondary to SIADH in Italy

NCT02573077 is registered in ClinicalTrials.gov with Otsuka Pharmaceutical Europe Ltd as lead sponsor.

NCT NCT02573077
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02573077 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Observational Study Measuring Sodium Improvement and Outcomes in Cancer Patients Treated for Moderate to Severe Hyponatremia Secondary to SIADH in Italy
Lead sponsor
Otsuka Pharmaceutical Europe Ltd
Phase
Observational
Overall status
Completed
Start date
October 31, 2015
Completion date
December 13, 2017
Enrollment
69 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, hyponatremia, syndrome of inappropriate adh (siadh) secretion